Study of furosemide on toxin removal in chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether the water pill furosemide can help remove certain toxins from the blood in people with chronic kidney disease (CKD stages 3-5) who are starting this medicine as part of their regular care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic kidney disease (CKD stage 3, 4, or 5) with an eGFR below 60 for at least 3 months.
- Your doctor has decided to start you on a water pill called furosemide as part of your routine treatment.
- You are willing to sign a consent form to take part in the study.
- You are not already taking furosemide.
- You do not have active liver disease causing jaundice, and you are not on dialysis or have end-stage kidney failure without any urine output.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how salt builds up in the skin of people with chronic kidney disease. It involves different groups testing either sodium intake, sodium excretion, or water intake to see how these affect blood pressure and kidney function.
This study checks how well diuretics (water pills) work in people with moderate chronic kidney disease. It may help doctors understand how to better treat fluid buildup in patients.
This study tests whether a furosemide (a water pill) stress test can help doctors decide when to safely stop continuous kidney replacement therapy in ICU patients with severe acute kidney injury. It may allow you to come off the machine sooner if your kidneys respond well.
This Phase 3 study tests whether using a “water pill” called furosemide during a flexible scope procedure helps leave fewer kidney-stone fragments behind. It may help reduce the chance of needing additional treatment later.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This study tests whether a specific water-based medication can prevent kidney damage when patients with acute heart failure need a CT scan with contrast dye. The trial focuses on people with mild-to-moderate kidney problems who are hospitalized for fluid buildup in the heart.
Hear when a new Chronic Renal Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.